Diversity in Clinical Pharmacology: A Call to Action-Reference-Cited by-同舟云学术

Diversity in Clinical Pharmacology: A Call to Action

Published:2023-01-29 Issue:3 Volume:113 Page:483-485
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Brown Karen¹^ORCID,Etrouth Shravani²^ORCID,Jayachandran Priya³^ORCID,Moore Jason⁴,Oni‐Orisan Akinyemi⁵^ORCID,Vasist Lakshmi⁶,Zheng Songmao⁷,Zhou Zhu⁸,Dresser Mark⁵⁹

Affiliation:

1. University of Montana Missoula Montana USA

2. Jawaharlal Nehru Technological University Hyderabad India

3. Pfizer Inc Cambridge Massachusetts USA

4. Office of Clinical Pharmacology, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

5. University of California San Francisco San Francisco California USA

6. GlaxoSmithKline Chapel Hill North Carolina USA

7. Adagene Inc San Diego California USA

8. York College The City University of New York Jamaica New York USA

9. Gilead Sciences Inc Foster City California USA

Abstract

Prioritization of diversity, equity, and inclusion in all facets of our work is long overdue for the clinical pharmacology community. Increasing diversity in clinical research will deepen our understanding of nuanced patient populations and help improve all patient outcomes. Fostering an inclusive and diverse workforce will lead to broader perspectives that can better inform critical decisions and create work environments where everyone can thrive. In this call to action, we invite you to join us.

Funder

City University of New York

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2852

Reference10 articles.

1. A roadmap to increase diversity in genomic studies

2. Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics

3. Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials

4. 2020 Drug Trials Snapshots Summary Report. (2021). Accessed June 9 2022.

5. The U.S. Public Health Service Syphilis Study at Tuskegee. . Accessed March 29 2022.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virtual twin for healthcare management;Frontiers in Digital Health;2023-09-15

2. Improving the Efficiency of Clinical Pharmacology Studies;Clinical Pharmacology in Drug Development;2023-06-23

3. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs;European Respiratory Journal;2023-06-15

4. Diversity, Equity, and Inclusion: Translating Clinical Pharmacology for All;Clinical Pharmacology & Therapeutics;2023-02-16